Amrutanjan Health Care

₹517.80As of Sun 8 Nov 2026, 12:00 UTC

NSE:AMRUTANJANHealthcare

Country India

PE (Fwd) 24.19

TSR 10Y CAGR 6.33%

Div yield 0.95%

ROE —

Drug Manufacturers (Specialty & Generic)

Beta (5Y) 0.42

PE TTM 25.85

TSR TTM (27.71%)

Mkt cap ₹14.95B

ROIC —

SE Grade™

Value

Quality

Moat

—

1Y Price

Reference

₹567

9.41%

(69.05%)

Price above Reference Value

TTM

FYE 31 Mar INR

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026

FY2027E

Trend

10Y

Peers

5.028

Revenue₹B

—

4.059

3.798

4.214

4.520

5.028

5.259

5.49%

11.24

Revenue growth%

—

(6.45)

10.96

7.26

11.24

4.60

9.11

—

50.31

Gross margin%

—

54.72

50.65

48.49

49.35

50.31

50.19

50.31

12.54

Operating margin%

—

19.67

11.02

11.21

11.78

12.54

12.27

11.78

11.52

Net margin%

—

16.55

10.49

10.67

11.25

11.52

11.33

11.25

25.85

P/E ratio (avg)x

—

34.64

54.93

42.24

42.44

33.17

25.12

42.24

23.75

EV/EBITx

—

29.15

52.28

40.21

40.51

30.48

23.20

40.21

—

FCF yield (avg)%

—

FCF margin%

—

FCF / Net incomex

—

ROIC%

—

Return on equity%

—

Return on assets%

—

20.03

EPS₹

—

22.98

13.63

15.50

17.58

20.03

20.61

(3.37%)

—

13.93

EPS growth%

—

(40.69)

13.70

13.46

13.93

2.88

13.58

—

Bookvalue per sh₹

—

FCF per share₹

—

4.90

Dividend per sh₹

—

4.60

4.90

5.07

1.59%

—

0.95

Div yield (avg)%

—

0.58

0.61

0.70

0.62

0.74

0.98

0.62

24.46

Payout ratio%

—

20.02

33.75

29.68

26.17

24.46

24.61

26.17

28.91

Shares (diluted)M

—

29.24

29.23

29.02

28.91

◌28.91

(0.28%)

—

Buyback yield%

—

0.03

0.71

0.38

—

◌—

0.21

—

D/E ratiox

—

14.97

Enterprise value₹B

—

23.27

21.88

19.00

21.58

19.21

14.97

(4.68%)

—

LT debt₹M

—

Peers (US$157.8M)

Cap (US$)

Beta Drugs Limited

194.9M

40.75x

Anlon Healthcare…

152.8M

31.51x

Jagsonpal Pharmaceutic…

149.8M

31.94x

Formosa Laboratories…

158.9M

11.17x

Capital

TTM

10Y

Leveragex

—

EBIT/Intx

323.3

301.5

Own earn%

—

Sh yield%

0.95

0.87

Owners

Insiders/Inst%

27.45

15.07

Short interest%

—

SBC / revenue%

(0.25)

Record

10Y

Profitable years

5/5

Revenue growth years

3/4

EPS growth years

3/4

Dividend streakyrs

Op margin range%

11–20

$1 testx

—

Incr. ROIC%

—

Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms and women hygiene products in India and internationally. It operates through OTC Products, Beverages, Women's Hygiene & Personal Care, and Others segments.

Growth vs revenue

Latest

Trend

4Y CAGR

Rel growth

Revenue

₹5.028B

5.49%

1.00×

Cost of revenue

₹2.498B

7.97%

1.10×

Operating expenses

₹1.899B

7.49%

1.08×

Revenue by region

No breakdown available

Reinvestment returns

n/m

Trend

Reinvestment rate

n/m

Return on capital

n/m

Spread over hurdle

n/m